Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ

6.11

+0.879(+16.81%)

Updated at October 08 03:25PM

Currency In USD

Valuation

Market Cap1.85B
Enterprise Value1.37B
P/E Ratio-3.61
PEG Ratio6.38
Price/Sales Ratio37.4
Price/Book Ratio2.55
Enterprise/Revenue30.57
Enterprise/EBITDA-3.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-10.07
Operating Margin-10.08

Management Effectiveness

Return On Assets-0.5
Return On Equity-0.76

Income Statement

Revenue58.84M
Revenue/Share0.15
Gross Profit13.6M
EBITDA-426.72M
Net Income-463.66M
Diluted EPS-1.69

Balance Sheet

Total Cash528.22M
Total Cash/Share1.27
Total Debt88.08M
Total Debt/Equity0.1
Current Ratio3.58
Book Value Per Share2.2

Price History

52-Week Change-12.91
52-Week High12.36
52-Week Low3.79
Moving Average 50 Days5.1
Moving Average 200 Days5.83

Statistics

Average Volume26.53M
Shares Outstanding429.71M
% Held by Institutions74.32

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A